EU’s First Stem Cell Treatment Recommended by EMA – Regulatory Focus
Regulatory Focus |
EU's First Stem Cell Treatment Recommended by EMA
Regulatory Focus A major milestone in stem cell therapy was reached in December 2014 when a European Medicines Agency (EMA) committee recommended the conditional approval of Holoclar, the first stem–cell product to be recommended for approval in the EU. |
